MAYAN TABLETS RELEASED BY MEXICAN GOVERNMENT.


This is really good news. Because just recently at a recent conference, Dr. Nassin Haramein gave a presentation with others on previously classified Mayan tablets found by the Mexican government. The government has now released some of the information for humanity, concluding that the events depicted in the tablet could either be an event from the past or an event to take place in the future.The information which has been protected for 80 years was expected to reveal the Mayan beliefs in future catastrophes and wisdom characterized as “shocking,” also the information about Mayan contact with extraterrestrials has been awaited, this has now been verified.

I believe this is very important for humanity, not just for Mexico. And considering that this information has been protected for 80 years, and how important it really is for people to understand the series of events that are coming, and the consequences for all of us.” This is what they stated before the announcement to release this new information.

When asked if the release will involve aliens, mystical elements or doomsday scenarios that have fueled the popular imagination, scientist`s declined to elaborate on that point.

“I’m not allowed to speak about that,” he said. “Everything is going to come out in time, but I can’t comment on aliens or on 2012.

“I can just say that the Mexican government is preparing to tell humanity and the world things that are critical for us, for the way we live, for the way we’ve been handling the planet.”  This he said then, now it`s very much verified.

The tablet shows clearly a planet with some type of habitable atmosphere, several ships, an extraterrestrial being, and more. This could quite possibly be a message from the Mexican government in wake of the Mayan date December 21, 2012. In the tablet one can make out a ship headed toward the planet (Earth) following a comet or massive object as another UFO or ship tries to deflect the object. The UFO is emerging from the sun, this could signify a future change in the sun. What is most interesting is that, these images depict contact with another race of space travelers.

Source:  http://soundofheart.org/galacticfreepress/content/mayan-tablets-released-mexican-government

Galactic Free Press.

 

 

Fall Asleep Faster by Taking This During the Day.


As you age, it becomes more difficult to get a good night’s sleep because your body becomes less efficient at making this hormone – taking this can help fix the problem while also boosting your energy, improving your mood and memory…*

Many experts previously believed that strict vegetarians were the primary group that could develop a vitamin B12 deficiency. If you had adequate stores of this important nutrient in your body, the experts believed you were “safe” for many years from developing a B12 deficiency.

Now we know better.

Vitamin B12 depletion and deficiency are much more common than previously thought, especially in the over-60 population. In fact, it’s believed that almost one in four people over 60 have deficient levels of this vital vitamin.

Equally disturbing are emerging signs that other age groups harbor suboptimal blood levels of B12 as well.

Why is vitamin B12 deficiency such a big deal?

Your body depends on vitamin B12 for a host of functions, including…

  • Helping to maintain normal energy levels*
  • Promoting healthy neurological activity, including mental alertness*
  • Supporting normal homocysteine levels for healthy cardiac function*
  • Helping to ease occasional stress and sleeplessness*
  • Maintaining healthy cell growth and repair*
  • Promoting normal immune function*
  • Supporting normal metabolism of carbohydrates and fats*

When your blood levels of vitamin B12 are low, one or more of these functions may be disrupted.*

Without adequate blood levels of B12, you can experience symptoms related to low energy, mental fatigue, mood changes, sleep difficulties, and even occasional indigestion.*

Your body relies on the efficient conversion of carbohydrates to glucose – your body’s source of fuel – just like your car needs to be able to use gas to run smoothly. Vitamin B12 plays a major role in that conversion in your body.* Likewise, B12 enables your body to convert fatty acids into energy as well.*

Contrary to what you might have heard, there’s really no solid evidence that supplemental vitamin B12 helps you lose weight.

Overall, vitamin B12 is a nutrient your body cannot do without for efficient, healthy metabolism of fats and carbohydrates.*

How You Get Vitamin B12 Deficient

The older you get the more likely you are to have a vitamin B12 deficiency. The two ways that you become deficient in vitamin B12 are from not getting enough in your diet and from losing the ability to absorb it.

I recently visited India which is primarily a vegetarian based culture and current studies there show about 80% of the adults are deficient in vitamin B12. However, vegans are not the only ones who can become vitamin B12 deficient.

The older you get the more your digestive system breaks down, especially if you have been following the standard American diet. Specifically the lining of your stomach gradually loses its ability to produce hydrochloric acid which releases vitamin B12 from your food. The use of antacids or anti-ulcer drugs will also lower your stomach acid secretion and decrease your ability to absorb vitamin B12. Infection with Helicobactor pylori, a common contributor to stomach ulcers, can also result in vitamin B12 deficiency.

However the main cause of vitamin B 12 deficiency is a term researchers call food-cobalamin malabsorption syndrome. Cobalamin is the scientific term for vitamin B12. This typically results when your stomach lining loses its ability to produce intrinsic factor which is a protein that binds to vitamin B12 and allows your body to absorb it at the end of your small intestine.

NEW Form of Vitamin B12 Not Found in Most Health
Food and Vitamin Stores

If you often feel tired, run-down, and lacking in energy, you’re not alone. Low energy is one of our country’s biggest health complaints.

Some of the top reasons for this are:

  • Refined foods sold in grocery stores are depleted of vital nutrients…
  • Refined foods are loaded with sugar…
  • Refined foods are full of chemicals…
  • Refined foods are overloaded with food colorings; and…
  • Refined foods are loaded with preservatives…

…but it doesn’t stop there, either.

Add the harmful effects of caffeine, pollution, conventional therapies, and the stress most of us experience everyday… and you’ve got yourself a recipe for energy drain.

Well, I’m here to tell you there’s a new way to give yourself extra energy.* Actually, a cutting edge way to feel more energized — without the jitteriness of caffeine.* More on this in a moment.

Now, of course, powering up with extra energy is just one of B12’s many health benefits.* But you need to…

Make Sure Your Vitamin B12 Is Made from This…

Otherwise, you could be wasting your time. How could that be?

Well, the answer simply put is… not all types of B12 (cobalamins) are created equal.

There are generally three main types of cobalamins used in B12 supplements…

Even though cyanocobalamin B12 is probably the most popular form of B12 in supplements, I don’t believe it’s the most effective. That distinction goes to methycobalamin (methyl B12).

And methyl B12 is the cobalamin compound of choice in B-12 Energy Booster* because…

  • Studies suggest that methyl B12 may be better utilized and retained in the body.*
  • Methyl B12 is the active form of vitamin B12 and evidence indicates it has some applications not shared by other forms of vitamin B12.*
  • With other forms of B12, your body must convert them into a coenzyme form for you to benefit. Not so with methyl B12… it’s already in the active coenzyme form naturally in your body.*

What Critical Health Benefits Does this Vitamin Bring to the Table?

For starters, vitamin B12 helps folic acid regulate the formation of red blood cells, and helps your body use iron.*

In addition, it is also needed for proper digestion, food absorption, carbohydrate and fat metabolism.* It also helps keep your nervous system healthy by assisting the nerves of your body to function and communicate in an optimal manner.*

But that’s not all…far from it!

B12 also helps in cell formation and cellular longevity.* Plus, it can support female reproductive health, and promote normal nerve growth and development by maintaining the fatty sheaths.* These fatty sheaths play a vital role as they cover and protect your nerve endings.*

What’s more, this workhorse of a micronutrient is critical to your circulation and adrenal hormone production — plus, it helps boost your immunity.* And, oh yes, let’s not forget…

Vitamin B12 supports a healthy mood and feelings of well-being.* And then there’s this — it also provides excellent support for your memory, mental clarity, and concentration.*

Aside from using B12 to give you an energy boost, when does it also make sense to supplement with this all-important vitamin? Well, there are several good reasons to take vitamin B12.

And the first reason to take it is if you are a carb type or a strict vegetarian.

What Critical Health Benefits Does this Vitamin Bring to the Table?

For starters, vitamin B12 helps folic acid regulate the formation of red blood cells, and helps your body use iron.*

In addition, it is also needed for proper digestion, food absorption, carbohydrate and fat metabolism.* It also helps keep your nervous system healthy by assisting the nerves of your body to function and communicate in an optimal manner.*

But that’s not all…far from it!

B12 also helps in cell formation and cellular longevity.* Plus, it can support female reproductive health, and promote normal nerve growth and development by maintaining the fatty sheaths.* These fatty sheaths play a vital role as they cover and protect your nerve endings.*

What’s more, this workhorse of a micronutrient is critical to your circulation and adrenal hormone production — plus, it helps boost your immunity.* And, oh yes, let’s not forget…

Vitamin B12 supports a healthy mood and feelings of well-being.* And then there’s this — it also provides excellent support for your memory, mental clarity, and concentration.*

Aside from using B12 to give you an energy boost, when does it also make sense to supplement with this all-important vitamin? Well, there are several good reasons to take vitamin B12.

And the first reason to take it is if you are a carb type or a strict vegetarian.

If You Avoid Meat, You Probably Need to Take B12

Many people avoid red meats for a large variety of reasons. If you are one of them, you are at a high risk for developing vitamin B12 deficiency. Why? Because plant sources have virtually no vitamin B12. And oral forms of B12 in nearly all supplements are practically useless, as little is absorbed into your bloodstream.

Vegetarians should take this essential micronutrient to ensure an adequate supply of it,because it is found almost exclusively in animal tissues. And, the few plant foods that are sources of B12 are actually B12 analogs — not the form that provides all the benefits of the real deal.

Simply put, an analog is a substance that blocks the uptake of true B12. The result being, your body’s need for the nutrient actually increases.

Furthermore, your body’s need for this nutrient may also increase if you take Metformin©. Metformin may interfere with calcium metabolism. And this interference may reduce B12 absorption, because this absorption requires calcium.

Studies suggest that 10% to 30% of patients taking Metformin show evidence of reduced vitamin B12 absorption. That’s why it is important to speak with your doctor to discuss the best way to maintain B12 levels when taking this medication.

Now, if getting a good night’s sleep has also become increasingly more difficult for you, here’s.

What Your Sleeping Difficulties May Be Trying to Tell You!

If you suffer from sleeping difficulties, I recommend taking vitamin B12 during the day. I believe it can help you.* Here’s why.

B12 plays a vital role in melatonin production.* Melatonin has been called “the sleep hormone” because it is responsible for letting you get a good night’s sleep.

As you age, it becomes increasingly more difficult to get a good night’s sleep because your body becomes less efficient at making this hormone. And that’s why it’s a good idea to take B12 to help you sleep like a baby each night.*

Moreover, a lack of adequate B12 can have other annoying consequences too.

Do You or a Loved One Experience Any of the Following?

Not many know it, but if you or a family member experience:

  • Tiredness and feelings of weakness…*
  • Less-than-optimal nervous system functioning…*
  • Less-than-optimal eye health…*
  • Loss of appetite and unintended weight loss…*
  • Occasional constipation and gas…*
  • Feelings of mild moodiness…*
  • Less-than-optimal memory…*
  • A tendency toward nervousness…*
  • Less-than-optimal balance…*
  • Less-than-optimal liver or heart health…*
  • Premature grey hair…*
  • Occasional digestive issues…*

you may need to supplement with vitamin B12, even if you eat foods rich in B12. Oddly enough, that wasn’t a typo.

You can eat plenty of meat, poultry, lamb’s liver, brewer’s yeast, clams, eggs, herring, mackerel, kidneys, milk, dairy products, or seafood — and still have low levels of B12. How can that be?

It could be because your body is unable to absorb it from your gut. You see B12 needs the help of a protein in order to be absorbed. That protein is called intrinsic factor. And because the lining of your stomach makes intrinsic factor, people with less-than-optimal gastrointestinal health often need to supplement with B12.*

Likewise, most people over the age of 50 have a limited ability to absorb B12, too.  Thus, the need for supplementation

Source: mercola.com/

HIV-infected T cells help transport the virus throughout the body.


Study using mouse model is first to allow observation of infected cells in living animal

A new study has discovered one more way the human immunodeficiency virus (HIV) exploits the immune system. Not only does HIV infect and destroy CD4-positive helper T cells – which normally direct and support the infection-fighting activities of other immune cells – the virus also appears to use those cells to travel through the body and infect other CD4 T cells. The study from Massachusetts General Hospital (MGH) investigators, which will appear in the journal Nature and has received advance online release, is the first to visualize the behavior of HIV-infected human T cells within a lymph node of a live animal, using a recently developed “humanized” mouse model of HIV infection.

“We have found that HIV disseminates in the body of an infected individual by ‘hitching a ride’ on the T cells it infects,” says Thorsten Mempel, MD, PhD, of the MGH Center for Immunology and Inflammatory Diseases, who led the study.  “Infected T cells continue doing what they usually do, migrating within and between tissues such as lymph nodes, and in doing so they carry HIV to remote locations that free virus could not reach as easily. There are drugs that can manipulate the migration of T cells that potentially could be used to help control the spread of virus within a patient.”

When HIV is introduced into blood or tissues, the virus binds to CD4 molecules on the surface of helper T cells, injecting its contents into cells and setting off a process that leads to the assembly and release of new virus particles. It has long been assumed that these free virus travel by diffusion through tissue fluids to encounter new cells that can be infected. But recent studies have suggested that HIV can also pass directly from cell to cell when structures called virological synapses form during long-lasting interactions between T cells. Since CD4 T cells usually migrate quickly and form only transient contacts with other cells, the current study was designed to examine whether HIV alters the migration of infected T cells, allowing the kind of persistent contact that facilitates the spread of infection.

The team’s experiments used the humanized BLT mouse model, which has what is essentially a human immune system and is the only non-primate that can be infected with HIV. After first confirming that human T cells enter and normally migrate within the animals’ lymph nodes – known to be important sites of HIV replication – the researchers injected the animals with HIV engineered to express green fluorescent protein (GFP), allowing them to track the movement of infected cells within living animals using a method called intravital microscopy. They first observed that, within two days, infected T cells continued to migrate and were uniformly distributed within lymph nodes but remained in nodes closest to the site of injection.

While the HIV-infected cells actively moved within lymph nodes, they did not move as quickly as comparable but uninfected T cells. In addition, 10 to 20 percent of the HIV-infected T cells formed abnormally long and thin extensions that appeared to trail behind moving cells, often exhibiting branches. The researchers hypothesized that the HIV envelope protein, which is expressed on the surface of infected T cells before they release new virus particles, might cause infected cells to form tethering contacts with uninfected cells, producing these extensions. A series of experiments verified that the elongated shape of some infected cells requires the presence of the envelope protein and that many of the elongated cells contained multiple nuclei, suggesting they had been formed by the fusion of several cells.

To test the role of T cell migration in HIV infection, the researchers injected another group of BLT mice with HIV and at the same time treated them with an agent that prevents T cells from leaving lymph nodes. Two months later, levels of HIV in the bloodstream and in lymph nodes distant from the site of injection were much lower than in untreated HIV-infected animals, supporting the importance of T cell migration to carry virus throughout the body. Treatment with the migration-suppressing agent, however, did not reduce viral levels in animals with already established HIV infection.

“While our observation of tethering interactions between infected and uninfected CD4-expressing cells suggest that HIV may be transmitted between T cells by direct contact, we will have to clearly show this in future studies and explore how important it is relative to the transmission by free virus,” explains Mempel, an assistant professor of Medicine at Harvard Medical School. He adds that the availability of the BLT mouse was instrumental in their ability to carry out this study. “This approach provides a new vantage point to investigate previously unexplored aspects of HIV pathogenesis.”

Source: Massachusetts General Hospital

 

 

Make breastfeeding easier for mothers, says UNICEF.


On the 20th anniversary of World Breastfeeding Week, UNICEF says strong national policies supporting breastfeeding could prevent the deaths of around 1 million children under five in the developing world each year.

Despite compelling evidence that exclusive breastfeeding prevents diseases like diarrhoea and pneumonia that kill millions of children every year, global rates of breastfeeding have remained relatively stagnant in the developing world, growing from 32 per cent in 1995 to 39 per cent in 2010.

“If breastfeeding were promoted more effectively and women were protected from aggressive marketing of breast milk substitutes, we would see more children survive and thrive, with lower rates of disease and lower rates of malnutrition and stunting,” said UNICEF Executive Director Anthony Lake.

Some of the roadblocks to improving breastfeeding rates are widespread and unethical marketing by makers of breast milk substitutes, poor national policies that do not support maternity leave, and a lack of understanding of the risks of not breastfeeding.

In June, world leaders meeting in Washington, D.C., pledged as part of the “Committing to Child Survival: A Promise Renewed” movement to work toward ending preventable child deaths. World Breastfeeding Week provides an opportunity to restate the critical role of breastfeeding in reducing child mortality.

The 2008 Lancet Nutrition Series highlighted the remarkable fact that a non-breastfed child is 14 times more likely to die in the first six months than an exclusively breastfed child. Breast milk meets a baby’s complete nutritional requirements and is one of the best values among investments in child survival as the primary cost is the mother’s nutrition.

“Breastfeeding needs to be valued as a benefit which is not only good for babies, mothers, and families, but also as a saving for governments in the long run,” said Mr. Lake.

Source: UNICEF.

 

 

 

Collusion Between Pharmaceutical Industry and Government Deepens.


There’s no shortage of stories detailing conflicts of interest—so many in fact that you may be getting sick and tired of hearing of them. However, this is a truly important issue that must be tackled, and one of the ways of doing that is by exposing it to the harsh light of day. As long as people remain unaware, or turn a blind eye, it will continue unabated.

The price we pay for not paying attention is the loss of health, as the information disseminated by grossly compromised health agencies is skewed in favor of various industries, with Big Pharma leading the pack as one of the most powerful political and governmental influences.

Here, I will review two important revolving-door cases, and while neither is recent news, many of you may still be unaware of them.

Former CDC Director Now President of Merck‘s Vaccine Unit

In the summer of 2011, Merck president Julie Gerberding said in a news interview1 that she’s “very bullish on vaccines,” as she recounted the various ways she helps Merck sell its products. What she didn’t divulge was her motivation for leaving her job as director of the Centers for Disease Control and Prevention (CDC)—an agency charged with overseeing vaccines and drug companies—and join Merck in the first place, back in January 2010.

If you don’t see the enormity of the influence her former high-level ties to the CDC can have, just consider the fact that Merck makes 14 of the 17 pediatric vaccines recommended by the CDC, and 9 of the 10 recommended for adults, and while vaccine safety advocates are trying to rein in the number of vaccines given to babies, safety concerns keep falling on deaf ears. The vaccine industry is booming, and it’s become quite clear that profit potential is the driving factor behind it.

One of the reasons for this is because vaccine patents do not expire like drugs do, so each vaccine adopted for widespread use has the potential to make enormous, continuous profits for decades to come. Vaccine makers also enjoy a high degree of immunity against lawsuits—and in the case of pandemic vaccines, absolute immunity—so the financial liability when something goes wrong is very low, compared to drugs.

Gerberding has a Long History of Disregard for Vaccine Safety

Joining a parade of other high-ranking government officials who pass through the revolving doors between government and Big Pharma, Gerberding left a trail of controversy behind her when she left the CDC. While a 2009 article by the Institute for Southern Studies lists a number of them2, I believe they left out the most important ones, namely her misinformation campaign about the pandemic swine flu vaccine, as well as her naive stance on vaccine safety issues in general.

The CDC disseminated extremely exaggerated data on the 2009 H1N1 “pandemic” and urged almost everyone in the U.S. to take the new, untested vaccines. When questions arose, they blocked CBS’s requests for samples of the swine flu cases and added obstacles to getting information. Despite the many dangers that have since been linked to the hastily developed vaccine—including the confirmed link to narcolepsy—the H1N1 vaccine is now part and parcel of the “regular” seasonal flu vaccine, although most people are completely unaware of this fact. And the CDC is now, for the first time ever, urging the seasonal flu vaccine on everyone in the country, from six months’ of age until death.

Even more disturbing, the CDC withheld data on miscarriages from the H1N1 vaccines under Gerberding’s lead, while insisting that pregnant women be put first in line to receive it. This was a dramatic reversal of its own recommendations. More than 3,500 post-vaccination miscarriages may have simply been ignored by the CDC.

One of Merck’s potentially most dangerous vaccines right now is Gardasil; a vaccine that so far has been linked to thousands of adverse events and at least 49 unexplained deaths. It’s a situation that the FDA and CDC have repeatedly denied, even as the adverse reports mount.

Gerberding’s 2004 report to Congress, ‘Prevention of Genital Human Papillomavirus Infection3 likely played a significant role in getting the controversial vaccine approved in the first place. Needless to say, the approval of this questionable vaccine guaranteed her future employer billions of dollars-worth of profits. Gerberding has also been a staunch defender of thimerosal, the mercury-based preservative used in many vaccines, and has consistently denied any links between vaccines and autism.

All in all, Gerberding has repeatedly demonstrated that safety is nowhere on her list of priorities or concerns when it comes to vaccines. It’s easy to see why Merck would want her to head up their vaccine unit. For the rest of us, however, her blatant disregard for proven vaccine safety is bad news indeed.

Former NIH Director Now Heads Sanofi Research Labs

Another former government official who’s switched sides is Elias Zerhouni, former director of the National Institutes of Health (NIH)—one of the world’s foremost medical research centers, and an agency of the US Department of Health and Human Services. Zerhouni is now head of Sanofi-Aventis’ research labs4. He also is a professor at Johns Hopkins School of Medicine; a member of the Board of Trustees at the Mayo Clinic; and is a senior fellow for the Bill & Melinda Gates Foundation’s Global Health Program5.

As pointed out in a recent article by Forbes Magazine6, Zerhouni is no stranger to controversies over conflicts-of-interest.

In the fall of 2003, the NIH with Zerhouni at its head faced grave accusations when it came to light that hundreds of its scientists had financial ties to the medical and pharmaceutical industries. According to a 2004 article in the NIH Record7, over 100 scientists did not get approval for their industry activities, even though the rules were so loose virtually all requests to conduct outside work were approved by the agency, without any limits on compensation or hours worked for outside entities.

In one case, an academic scientist was found to have a financial interest in a therapy that ended up killing a patient. The case served as a potent warning of how dangerous such conflicts of interest can be. While Zerhouni managed to emerge from the 2003 debacle looking like a good crisis manager, the following paragraphs from the NIH Record8 are quite telling. Essentially, Zerhouni dissuaded Congress from doing the right thing, which is ban all outside activities of those working for the NIH, limiting the restrictions for conflicts of interest to upper level management only:

“[Zerhouni] disclosed that “initially, Congress truly wanted to ban [all outside activities], and the members of the committee have been very public about that…I was fortunate to be able to make contact with legislators and to help them understand what happened, how it happened, and why [a draconian response] might not be the right thing to do.”

Zerhouni said that over the course of long discussion, a good consensus emerged that formed the basis of NIH’s approach to the issue: stewards of public funds should never be vulnerable even to the perception that their activities could result in private gain. The top concern, he said, is, “How do you keep a true firewall and separation between the public trust — the money the public has given us in trust — and the activities of those who manage that resource?”

He doesn’t think it was well appreciated outside of NIH that the agency “has a dual nature — number one, we are a granting agency, but number two, we are also one of the most advanced, most capable biomedical research institutions in the world.

So we’re both sort of an academic, scientific research place, and yet next to that we’re also a government agency with its own rules and regulations…I said, look, we need to build a firewall around those who have fiduciary responsibility relative to the government, and those who do not. And that’s where we came up with these much more stringent rules for directors, deputy directors, and people who have those authorities, versus those who do not.”

Conflicts of Interest Affect Your Life and Well-Being…

When it comes to medicine, mere disclosure of conflict of interest is not nearly enough. Patients need unbiased advice when it comes to making decisions that can impact their very life, and physicians and scientists with financial ties to the drug industry should not be allowed to participate in broad policy and public-health recommendations in the first place. Likewise, while it’s perfectly legal to engage the revolving door and switch jobs from government agencies to private industry and vice-versa, this practice has become so widespread it has undermined the entire system of checks and balances.

Conflict of interest is rampant not only within the field of medicine, but the revolving doors between government and industry has effectively led to a situation where it’s now extremely difficult, if not impossible, to trust conventional health advice from the federal government—which is supposed to be independent due to this massive collusion between government and industry. Here are a few more examples of the many revolving doors between the pharmaceutical industry and the US government:

  • The American Cancer Society has close financial ties to both makers of mammography equipment and cancer drugs. Other conflicts of interest include ties to, and financial support from, the pesticide, petrochemical, biotech, cosmetics, and junk food industries—the very industries whose products are the primary contributors to cancer
  • Drug companies pay seven-figure amounts into FDA coffers to gain approval of their drugs. FDA staff knows that the cash means higher salaries and more perks in the agency budget. (Incidentally, the FDA’s commissioner Margaret Hamburg came straight from the boardroom of America’s largest seller of dental amalgam, Henry Schein, Inc.)
  • Conflicts of interest are also rampant in a mass vaccination infrastructure that has the same people who are regulating and promoting vaccines also evaluating vaccine safety.
  • The vaccine industry gives millions for conferences, grants, and medical education classes sponsored by the American Academy of Pediatrics (AAP). The vaccine industry even helped build AAP’s headquarters.
  • President Obama’s nominee at the Department of Homeland Security overseeing bioterrorism defense, Dr. Tara O’Toole, served as a key advisor for a lobbying group funded by a pharmaceutical company that asked the government to spend more money for anthrax vaccines and biodefense research9

There are countless others—so many, in fact, I’m sure you could fill an entire book with examples. These types of blatant conflicts should simply not be tolerated, but they most certainly are. For now the majority still does not understand the pharmaceutical industry’s power and influence over government, and the field of conventional medicine itself, but the tide is beginning to turn, and will continue to do so as more and more people get informed.

What Can You do to Take Control of Your Health?

The good news is that increasing numbers of people are now waking up to these harsh realities, and you, being among those who are informed, can help share this knowledge with others. Remember that the definition of fascism is a government system that has complete power in regimenting all industry and forcibly suppressing opposition and criticism. What we have here is a hybrid—a sort of corporate fascism, where industry has powerful control over government, and forcefully suppresses anything that threatens their monopoly on profits.

Unfortunately, this can be extremely dangerous as it pertains to your health.

Virtually every measurable index indicates that despite the ever-increasing amounts of money invested, if you live in the United States your chance of achieving optimal health through the medical system is only getting worse. While the U.S. spends more than twice the amount on health care as other developed nations, we rank 49th in life expectancy worldwide—far lower than most other developed nations! The time is ripe for you to take control of your health, and this site is full of free comprehensive recommendations that can serve as an excellent, truly independent starting point.

When it comes to your health, you simply cannot accept claims at their face value … you’ve got to dig below the surface and use all the resources available to you, including your own commonsense and reason, true independent experts’ advice and other’s experiences, to determine what medical treatment or advice will be best for you in any given situation. Ultimately, you must come to the realization that YOU are responsible for your, and your family’s health — not me, not your physician, and certainly not any researchers or government health agencies on a drug or vaccine manufacturer’s payroll.

You’ve got to become an active participant in your care and make sure you are making decisions that correspond with your own best judgment, knowledge and experiences.

Source: Dr. Mercola.

 

Proton-Pump Inhibitors Raise Risk for C. difficile Infections.


In two meta-analyses, PPI use was associated with a 1.7-fold higher risk for Clostridium difficile infection.

In February 2012, the FDA issued a safety alert regarding an association between proton-pump inhibitors (PPIs) and Clostridium difficile infection. In new meta-analyses, two groups of researchers used slightly different criteria to select studies in which this association could be evaluated; all included studies (23 and 42, respectively) were observational (cohort or case-control). Each meta-analysis involved roughly 300,000 patients.

In both meta-analyses, risk for C. difficile infection was significantly higher in PPI users than in nonusers (risk ratio, about 1.7). Although results across individual studies were heterogeneous, nearly all trended toward higher risk. Most of the included studies were adjusted for confounding variables, including antibiotic use. Concomitant use of both PPIs and antibiotics — examined in one meta-analysis — was associated with greater risk for C. difficile infection than was use of PPIs alone or antibiotics alone. Risk for C. difficile infection was higher with histamine (H)2-receptor antagonists than with no acid-suppressive therapy, but lower with H2-receptor antagonists than with PPIs.

Comment: The opportunity for residual confounding in these studies is substantial, because sicker patients are more likely both to receive PPIs and to be vulnerable to C. difficile infection. Still, these worrisome findings should remind clinicians to initiate PPIs only for valid indications and to stop PPIs in patients who take them for unclear reasons.

Source:Journal Watch General Medicine

CDC Seeing More West Nile Virus Disease .


West Nile virus appears to be making a comeback this year, the CDC reports. So far, the agency has received reports of 241 cases of West Nile virus disease, including 4 deaths.

Nearly 80% of the cases were from Texas, Mississippi, and Oklahoma, but infections in people, birds, or mosquitoes have been reported in 42 states.

This is the highest number of cases for this time of year since 2004. The number of infections typically peaks in August. CDC officials say it is not clear why there is more activity this year.

Source: CDC news

Glucocorticoid-Induced Cushing Syndrome Linked to Increased Risk for CV Events .


Among patients taking glucocorticoids, those who develop iatrogenic Cushing syndrome have more than twice the risk for cardiovascular events as those who do not develop the condition, according to a BMJ study.

Using national U.K. databases, researchers studied some 550 patients who exhibited Cushing syndrome while taking glucorticoids, 3000 taking glucocorticoids who did not develop Cushing syndrome, and 3000 not taking the drugs. In adjusted analyses, the rate of cardiovascular events per 100 person-years was 15.1 among patients with Cushing syndrome, 6.4 among glucocorticoid users without Cushing syndrome, and 4.1 among nonusers.

The authors write: “Glucocorticoid induced cushingoid appearance should no longer be considered as a minor adverse event of glucocorticoids.” They add that those who do exhibit Cushing syndrome “should be aggressively targeted for early screening and management of cardiovascular risk factors.”

Source: BMJ

Acadesine Does Not Improve Outcomes of CABG.


In a randomized trial, an adenosine-regulating agent had no apparent cardioprotective effect.

Despite advances in surgical technology, ischemia/reperfusion injury associated with coronary artery bypass grafting (CABG) remains an important cause of morbidity and mortality. To evaluate the protective effect of acadesine, an adenosine-regulating agent, investigators at 300 sites in 7 countries conducted a manufacturer-sponsored, randomized, double-blind, placebo-controlled trial involving intermediate- or high-risk patients undergoing nonemergent, on-pump CABG during 2009–2010. The primary composite endpoint was all-cause mortality, nonfatal stroke, or mechanical support for severe left ventricular dysfunction during CABG or 4 weeks of follow-up.

The trial was stopped for futility after enrollment of 30% of the projected study population. The final cohort included 2986 patients (median age, 66), most of whom were white men with hyperlipidemia, diabetes, and family history of cardiovascular disease. The primary-endpoint rate was 5.0% overall and did not differ significantly between the placebo and acadesine groups (5.0% and 5.1%, respectively), as demonstrated by a Kaplan-Meier curve. No between-group difference in the rate of any secondary endpoint reached or approached statistical significance, nor was any significant difference found among groups stratified by Society of Thoracic Surgeons risk quintile.

Comment: Although previous studies yielded promising findings, this well-designed trial failed to show any benefit of acadesine on outcomes in intermediate- or high-risk patients undergoing coronary artery bypass grafting. The rate of the primary endpoint, although lower than the 10% expected with placebo in this population, underscores the need for continued efforts to prevent ischemia/reperfusion injury during and after CABG.

Source: Journal Watch Cardiology

Pertussis on the Rise.


Pertussis reached epidemic proportions in Washington State in 2012, apparently because of waning immunity in individuals who received acellular vaccines during childhood.

Pertussis incidence has been increasing since mid-2011 in the state of Washington. The number of cases reported in early 2012 — 2520 — was 1300% higher than the number during the same period in 2011. Rates were highest among infants aged <1 year, children aged 10 years, and adolescents fully vaccinated with tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine. Incidence among Hispanics was more than twice that among non-Hispanics (53.1 vs. 24.6 cases per 100,000 population).

A total of 2069 cases were confirmed by laboratory testing (83%) or epidemiologic linking (17%). Multitarget polymerase chain reaction (PCR) assays, performed on 193 specimens in which Bordetella DNA had been detected by PCR, identified B. pertussis in 175 (91%) and B. parapertussis in 11 (6%). Thirty (55%) of the 55 isolates subjected to pulsed-field gel electrophoresis represented the four most commonly identified profiles in the CDC’s national database.

Valid vaccination history was available for 91% of the patients aged 3 months to 19 years. Seventy-six percent of the patients aged 3 months to 10 years were up to date with childhood diphtheria and tetanus toxoids and acellular pertussis doses; 43% of those aged 11 to 12 years and 77% of those aged 13 to 19 years had received the Tdap vaccine recommended for older children and adults.

Although the incidence of pertussis nationwide in early 2012 was far lower than that in Washington State (4.2 vs. 37.5 cases per 100,000), it also peaked among infants and among children aged 10, 13, and 14 years. Across the U.S., the case fatality rate showed a slight decrease from the previous decade.

Comment: Acellular vaccines replaced the older whole-cell products because of adverse events associated with the latter. It now appears that protection by the acellular vaccines, although lasting several years, may wane, leaving large populations unprotected against pertussis. Nonetheless, vaccination and revaccination remain the primary shields against infection.

Source: Journal Watch Infectious Diseases.